Yunkang Group Limited (HKG:2325)
Hong Kong · Delayed Price · Currency is HKD 0.6500
-0.0100 (-1.52%)
Jul 10, 2026, 3:30 PM HKT
Yunkang Group Market Cap
Yunkang Group has a market cap or net worth of 380.47 million as of July 10, 2026. Its market cap has decreased by -81.94% in one year.
Market Cap
380.47M
Enterprise Value
-737.35M
Revenue
669.23M
Ranking
n/a
PE Ratio
117.10
Stock Price
0.65
Market Cap Chart
Since May 18, 2022, Yunkang Group's market cap has decreased from 5.21B to 380.47M, a decrease of -92.70%. That is a compound annual growth rate of -46.79%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jul 10, 2026 | 380.47M | -34.34% |
| Dec 31, 2025 | 579.49M | -89.52% |
| Dec 31, 2024 | 5.53B | -25.83% |
| Dec 29, 2023 | 7.46B | -25.55% |
| Dec 30, 2022 | 10.01B | 92.14% |
| May 18, 2022 | 5.21B | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| WuXi XDC Cayman | 76.10B |
| Adicon Holdings | 2.81B |
| Guanze Medical Information Industry (Holding) | 2.30B |
| Mega Genomics | 1.45B |
| Kindstar Globalgene Technology | 977.17M |
| China Biotech Services Holdings | 595.20M |
| Biosino Bio-Technology and Science Incorporation | 321.25M |
| Zhong Ji Longevity Science Group | 318.33M |